[go: up one dir, main page]

IT1294191B1 - Composition for treating osteoporosis, Paget's disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution - Google Patents

Composition for treating osteoporosis, Paget's disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution

Info

Publication number
IT1294191B1
IT1294191B1 ITBO970538A IT1294191B1 IT 1294191 B1 IT1294191 B1 IT 1294191B1 IT BO970538 A ITBO970538 A IT BO970538A IT 1294191 B1 IT1294191 B1 IT 1294191B1
Authority
IT
Italy
Prior art keywords
sodium chloride
chloride solution
hypercalcemia
paget
disease
Prior art date
Application number
Other languages
Italian (it)
Inventor
Leone Gabriele Rotini
Salvatore Mardente
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Priority to IT97BO000538 priority Critical patent/IT1294191B1/en
Publication of ITBO970538A0 publication Critical patent/ITBO970538A0/en
Priority to TR1998/01018A priority patent/TR199801018A3/en
Priority to ES9801849A priority patent/ES2151838B1/en
Publication of ITBO970538A1 publication Critical patent/ITBO970538A1/en
Application granted granted Critical
Publication of IT1294191B1 publication Critical patent/IT1294191B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Calcitonin is dissolved in a sodium chloride solution altered to a pH of 3.5-4.5 using a solution containing citrate and hydrochloric acid. A pharmaceutical composition comprises calcitonin dissolved in a physiologically compatible sodium chloride solution with a pH altered to 3.5-4.5 using a preservative-free solution of citrate and hydrochloric acid. The compositions are applied using a powder dosing device, the mouth of which is coupled to a dosing pump and hermetically sealed.
IT97BO000538 1997-09-05 1997-09-05 Composition for treating osteoporosis, Paget's disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution IT1294191B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT97BO000538 IT1294191B1 (en) 1997-09-05 1997-09-05 Composition for treating osteoporosis, Paget's disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution
TR1998/01018A TR199801018A3 (en) 1997-09-05 1998-06-04 Pharmaceutical compositions containing calcitonin in a spray feeder for intranasal administration.
ES9801849A ES2151838B1 (en) 1997-09-05 1998-09-02 PHARMACEUTICAL COMPOSITIONS CONTAINING CALCITONIN IN A SPRAY DOSER FOR INTRANASAL ADMINISTRATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97BO000538 IT1294191B1 (en) 1997-09-05 1997-09-05 Composition for treating osteoporosis, Paget's disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution

Publications (3)

Publication Number Publication Date
ITBO970538A0 ITBO970538A0 (en) 1997-09-05
ITBO970538A1 ITBO970538A1 (en) 1999-03-05
IT1294191B1 true IT1294191B1 (en) 1999-03-22

Family

ID=11342512

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97BO000538 IT1294191B1 (en) 1997-09-05 1997-09-05 Composition for treating osteoporosis, Paget's disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution

Country Status (3)

Country Link
ES (1) ES2151838B1 (en)
IT (1) IT1294191B1 (en)
TR (1) TR199801018A3 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
DE3726324A1 (en) * 1987-08-07 1989-02-16 Hoechst Ag CYCLOPEPTIDE AS RESORPTION FOLDER IN APPLICATION TO THE MEAT
HU206367B (en) * 1988-04-30 1992-10-28 Sandoz Ag Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
IL91856A0 (en) * 1988-10-11 1990-06-10 Schiapparelli Salute Spa Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
EP0489217A1 (en) * 1990-12-05 1992-06-10 Dr. A. Tosi Farmaceutici S.R.L. Calcitonin compositions for intranasal administration
IT1251685B (en) * 1991-10-11 1995-05-19 Isf Spa PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN

Also Published As

Publication number Publication date
TR199801018A2 (en) 1999-11-22
ES2151838A1 (en) 2001-01-01
TR199801018A3 (en) 1999-11-22
ES2151838B1 (en) 2001-08-16
ITBO970538A1 (en) 1999-03-05
ITBO970538A0 (en) 1997-09-05

Similar Documents

Publication Publication Date Title
EP0183527B1 (en) Absorbable calcitonin medicament
ES2190244T3 (en) USE OF THE PARTIROID HORMONE CONSTITUTED BY A SEQUENCE OF AMINO ACIDS 1-34 OF THE HUMAN PARTIROID HORMONE TO REDUCE THE RISK OF VERTEBRAL AND NON-VERTEBRAL BONE FRACTURES.
MY112285A (en) Oral liquid alendronate formulations
ATE284657T1 (en) ORAL PHARMACEUTICAL PRODUCTS CONTAINING PEPTIDES
IL166787A0 (en) A delivery system and a manufacturing process of adelivery system
EP0998916A4 (en) Medicinal compositions for application to mucosa
EP0287927A3 (en) Conditioning liquid for osseous or dental substance
IL132201A0 (en) Stabilized human papillomavirus formulations
TW286320B (en)
HUP9801414A2 (en) Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
KR900016253A (en) Acid addition salt of amidated taurine or glycine, its preparation method and its use
ZA200308625B (en) Orally administering parathyroid hormone and calcitonin.
IT1294191B1 (en) Composition for treating osteoporosis, Paget's disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution
EP1721617A2 (en) Dental therapeutics containing parathyroid hormone
MY102411A (en) Nasal solutions
JPS56140924A (en) Calcitonin pharmaceutical preparation
CA2347330A1 (en) Liquid injectable formulation of disodium pamidronate
WO2004084859A3 (en) Nasal calcitonin formulations containing chlorobutanol
DE60001489D1 (en) PHARMACEUTICAL PREPARATION FOR THE INTRAVENOUS OR INTRAMUSCULAR ADMINISTRATION OF OCTREOTIDE
JPS61126034A (en) Transnasal carcitonin agent containing aldose
IT1238074B (en) Composites for Paget's disease, hypercalcemia and osteoporosis obtained by complexation of one of the calcitonins with a cyclodextrin, preparation and relative pharmaceutical composition.
SE9901170L (en) Medication for psoriasis
IT1262960B (en) Pharmaceutical compositions which can be administered intranasally containing calcitonin as active ingredient
UA36162A (en) Method for modeling polyuric form of acute renal failure

Legal Events

Date Code Title Description
0001 Granted